CXCL12 and diabetes mellitus: Although animal studies have shown reduced SDF-1 expression in diabetic cutaneous wounds and SDF-1 treatment has shown to reverse the diabetic defect in EPC homing in diabetic mice [26], there is limited information in DM patients.